Chris Yamamoto serves as Senior Vice President of Business Development and Strategy and is responsible for identifying, evaluating and executing inorganic growth opportunities across Bioventus. Chris has nearly 20 years of experience in mergers & acquisitions and business development having completed numerous transactions amounting to over $50 billion in value.

Prior to joining Bioventus, Chris was Vice President and Managing Director of Corporate Development at Becton Dickinson and Company. During his six years at Becton Dickinson, Chris played an instrumental role in transforming the company through two large-scale acquisitions (C.R. Bard and CareFusion), executing nearly 30 tuck-in acquisitions and equity investments and divesting a number of non-core businesses. Prior to Becton Dickinson, Chris was a Vice President at The Blackstone Group. Chris also worked at Fox Paine, Thoma Cressey, UBS Investment Bank and other institutions.

Chris received a Bachelor of Arts in Economics cum laude from Williams College.